title: Recent advances of cowpea mosaic virus-based particle technology.
abstract: Particles of cowpea mosaic virus (CPMV) have enjoyed considerable success as a means of presenting peptides for vaccine purposes. However, the existing technology has limitations in regard to the size and nature of the peptides which can be presented and has problems regarding bio-containment. Recent developments suggest ways by which these problems can be overcome, increasing the range of potential applications of CPMV-based particle technology.
authors.affiliation: Department of Biological Chemistry, John Innes Centre, Norwich, UK.
authors.forename: Nicholas P
authors.initials: NP
authors.lastname: Montague
authors.forename: Eva C
authors.initials: EC
authors.lastname: Thuenemann
authors.forename: Pooja
authors.initials: P
authors.lastname: Saxena
authors.forename: Keith
authors.initials: K
authors.lastname: Saunders
authors.forename: Paolo
authors.initials: P
authors.lastname: Lenzi
authors.forename: George P
authors.initials: GP
authors.lastname: Lomonossoff
mesh_terms: D002678:Chimera / Q000235:genetics; D017798:Comovirus / Q000235:genetics*; D018744:DNA, Plant / Q000096:biosynthesis; D004279:DNA, Viral / Q000008:administration & dosage; D005822:Genetic Vectors; D012367:RNA, Viral / Q000378:metabolism; D014612:Vaccines / Q000096:biosynthesis*; D015678:Viral Structural Proteins / Q000008:administration & dosage / Q000737:chemistry
chemical_list: D018744:DNA, Plant; D004279:DNA, Viral; D012367:RNA, Viral; D014612:Vaccines; D015678:Viral Structural Proteins